Prenetics Global Limited Revenue Growth Rates (PRE), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Prenetics Global Limited  (NASDAQ: PRE)
 

PRE's Revenue Growth by Quarter and Year

Prenetics Global Limited's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/PRE/growth
https://api.csimarket.com/api/v1/companies/PRE/fundamentals
https://api.csimarket.com/api/v1/companies/PRE/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
PRE Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 46.49
1st Quarter March 35.95
FY 82.44





PRE Revenue second quarter 2026 Y/Y Growth Comment
Prenetics Global Limited achieved in the second quarter 2026, above Company average Revenue surge of 210.75% year on year, to $ 46.49 millions.

According to the results reported in the second quarter 2026, Prenetics Global Limited achieved the best Revenue growth in Laboratory Analytical Instruments industry. While Prenetics Global Limited' s Revenue doubling of 210.75% ranks overall at the positon no. 221 in the second quarter 2026.


PRE Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 210.75 %
1st Quarter March 107.68 %
FY   -

Financial Statements
Prenetics Global Limited's second quarter 2026 Revenue $ 46.49 millions PRE's Income Statement
Prenetics Global Limited's second quarter 2025 Revenue $ 14.96 millions Quarterly PRE's Income Statement


PRE Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 29.31 %
1st Quarter March -60.83 %
FY (Year on Year)   -


Back to PRE Growth rate Comparisons >> Back to PRE Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #0
Healthcare Sector #58
Overall #221

Revenue Y/Y Growth Statistics
High Average Low
210.67 % 124.08 % -92.12 %
(Dec 31 2025)   (Dec 31 2024)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #0
Healthcare Sector #58
Overall #221
Revenue Y/Y Growth Statistics
High Average Low
210.67 % 124.08 % -92.12 %
(Dec 31 2025)   (Dec 31 2024)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Prenetics Global Limited's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
290.85 % 36.62 % -100 %
(Dec 31 2024)  


PRE's II. Quarter Q/Q Revenue Comment
Prenetics Global Limited achieved in the II. Quarter 2026 below company average Revenue jump of 29.31% quarter on quarter, to $ 46.49 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -13.58% in the II. Quarter a year ago.

Within Laboratory Analytical Instruments industry only one company achieved higher sequential Revenue growth. While Prenetics Global Limited's Revenue growth quarter on quarter, overall rank is 593.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #2
Healthcare Sector #136
Overall #593
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #2
Healthcare Sector #136
Overall #593
Revenue Q/Q Growth Statistics
High Average Low
290.85 % 36.62 % -100 %
(Dec 31 2024)  


PRE's II. Quarter Q/Q Revenue Comment
Prenetics Global Limited achieved in the II. Quarter 2026 below company average Revenue jump of 29.31% quarter on quarter, to $ 46.49 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -13.58% in the II. Quarter a year ago.

Within Laboratory Analytical Instruments industry only one company achieved higher sequential Revenue growth. While Prenetics Global Limited's Revenue growth quarter on quarter, overall rank is 593.


Prenetics Global Limited's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)		 12 Months Ending (Dec 31 2024) 12 Months Ending (Dec 31 2023) 12 Months Ending 12 Months Ending
Cumulative Revenue 12 Months Ending $ 91.79
Y / Y Revenue Growth (TTM) 201.94 %
Year on Year Revenue Growth Overall Ranking # 339
Seqeuential Revenue Change (TTM) 201.94 %
Seq. Revenue Growth (TTM) Overall Ranking # 339


Cumulative Revenue growth Comment
With 201.94% annual Revenue growth, Prenetics Global Limited would report a record annual Revenue surge if the fiscal year would end on Dec 31 2025.

In the Healthcare sector 78 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 339, from total ranking in previous quarter at 3285.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 2
Healthcare Sector # 79
Overall # 339

Revenue TTM Y/Y Growth Statistics
High Average Low
201.94 %
 102.31 %
39.82 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 79
S&P 500 # 339
Cumulative Revenue growth Comment
With 201.94% annual Revenue growth, Prenetics Global Limited would report a record annual Revenue surge if the fiscal year would end on Dec 31 2025.

In the Healthcare sector 78 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 339, from total ranking in previous quarter at 3285.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 2
Healthcare Sector # 79
Overall # 339

Revenue TTM Y/Y Growth Statistics
High Average Low
201.94 %
102.31 %
39.82 %
 






Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PRE's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue surge for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Vireo Growth Inc.335.47%$ 335.470 millions
Dianthus Therapeutics Inc 294.30%$ 294.301 millions
Miragen Therapeutics Inc 278.67%$ 278.667 millions
Alpha Cognition Inc.267.56%$ 267.556 millions
Agios Pharmaceuticals Inc 259.25%$ 259.253 millions
Omniab Inc 244.24%$ 244.239 millions
Medicinova Inc 240.60%$ 240.596 millions
Clene Inc 233.33%$ 233.333 millions
Editas Medicine Inc 232.31%$ 232.309 millions
Prenetics Global Limited210.67%$ 210.666 millions
Urogen Pharma Ltd 206.17%$ 206.174 millions
Sintx Technologies Inc 199.34%$ 199.338 millions
Arrowhead Pharmaceuticals Inc 171.02%$ 171.016 millions
Cue Biopharma Inc 166.66%$ 166.655 millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________162.99%$ 162.992 millions
Cormedix Inc 156.52%$ 156.515 millions
Ataibeckley Inc 137.00%$ 136.996 millions
Pavmed Inc 135.71%$ 135.714 millions
Xilio Therapeutics Inc 131.22%$ 131.222 millions
Tenon Medical Inc 126.77%$ 126.773 millions
Sonida Senior Living Inc 122.02%$ 122.024 millions
Bridgebio Pharma Inc 120.39%$ 120.392 millions
Autolus Therapeutics Plc118.37%$ 118.367 millions
Neuraxis Inc 115.72%$ 115.717 millions
Renovorx Inc 115.40%$ 115.403 millions
Ars Pharmaceuticals Inc 114.15%$ 114.150 millions
Foghorn Therapeutics Inc 112.68%$ 112.677 millions
60 Degrees Pharmaceuticals Inc 106.04%$ 106.044 millions


About Prenetics Global Limited Revenue Growth Rates (PRE), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Prenetics Global Ltd (CIK 1876431).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-028623
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Prenetics Global Ltd’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.